Chetan Pai, DO
Gastroenterology · Fredericksburg, VANPI 1649488230
Payments from drug & device makers
Across 455 payments — averaging $46.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Takeda Pharmaceuticals U.S.A., Inc.$814
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$682
- Boston Scientific$375
- Johnson & Johnson$315
- Gilead$312
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$13,65064%
- Travel & lodging$1651%
- Food & beverage$7,40635%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 213 | $16,633 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $814 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 37 | $682 |
| Boston Scientific | 6 | $375 |
| Johnson & Johnson | 16 | $315 |
| Gilead | 17 | $312 |
| QOL Medical, LLC | 21 | $267 |
| Ironwood Pharmaceuticals, Inc | 11 | $198 |
| Sanofi | 8 | $195 |
| Pfizer | 7 | $137 |
| Bristol Myers Squibb | 7 | $121 |
| Medtronic | 2 | $120 |
| Ipsen Biopharmaceuticals, Inc | 1 | $113 |
| Ardelyx, Inc. | 7 | $110 |
| Nestle Healthcare Nutrition Inc. | 5 | $109 |
| Phathom Pharmaceuticals, Inc. | 7 | $108 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 4 | $55 |
| Novo Nordisk | 2 | $50 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| Merck | 3 | $47 |
| UCB, Inc. | 2 | $44 |
| Merit Medical Systems Inc | 2 | $38 |
| Braintree Laboratories, Inc. | 3 | $37 |
| Intercept Pharmaceuticals, Inc. | 2 | $28 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Organon | 2 | $26 |
| Vivus LLC | 1 | $24 |
| Celltrion USA Inc. | 1 | $24 |
| Amgen | 1 | $17 |
| Shionogi Inc | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Romark Laboratories, LC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,235 in reported general payments places this provider in the 80th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $117,217 |
| LinzessLinaclotide | 70 | $59,488 |
| CreonLipase/Protease/Amylase | 16 | $43,209 |
| XifaxanRifaximin | 14 | $43,081 |
| Dexlansoprazole DrDexlansoprazole | 56 | $14,944 |
| Pantoprazole Sodium | 481 | $7,933 |
| Esomeprazole Magnesium | 45 | $2,388 |
| CholestyramineCholestyramine (With Sugar) | 26 | $2,363 |
| Omeprazole | 187 | $2,256 |
| Sucralfate | 31 | $2,253 |
| Famotidine | 133 | $1,242 |
| Colestipol Hcl | 14 | $727 |
| Dicyclomine Hcl | 38 | $593 |
| Ondansetron Hcl | 24 | $440 |
| Ondansetron OdtOndansetron | 24 | $286 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $16,633 | $102,69686 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $682 | $43,08114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 473 gastroenterology providers in Virginia.
Other gastroenterology in Fredericksburg
- Narayan DharelFredericksburg$63K
- Larry ClarkLynchburg$8.5M
- Arun SanyalRichmond$5.5M
- Mitchell ShiffmanNewport News$4.7M
- Jasmohan BajajRichmond$4.4M
- Michael FuchsRichmond$1.9M
- Stephen CaldwellCharlottesville$1.8M
- Nirish ShahRoanoke$1.7M
- Michael RyanNorfolk$1.5M
- Omer KhalidNorth Chesterfield$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.